Literature DB >> 21400555

Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis.

Shinji Shimoda1, Kenichi Harada, Hiroaki Niiro, Ken Shirabe, Akinobu Taketomi, Yoshihiko Maehara, Koichi Tsuneyama, Yasuni Nakanuma, Patrick Leung, Aftab A Ansari, M Eric Gershwin, Koichi Akashi.   

Abstract

UNLABELLED: Primary biliary cirrhosis (PBC) is characterized by chronic nonsuppurative destructive cholangitis (CNSDC) associated with destruction of small bile ducts. Although there have been significant advances in the dissection of the adaptive immune response against the mitochondrial autoantigens, there are increasing data that suggest a contribution of innate immune mechanisms in inducing chronic biliary pathology. We have taken advantage of our ability to isolate subpopulations of liver mononuclear cells (LMC) and examined herein the role of Toll-like receptors (TLRs), their ligands, and natural killer (NK) cells in modulating cytotoxic activity against biliary epithelial cells (BECs). In particular, we demonstrate that Toll-like receptor 4 ligand (TLR4-L)-stimulated NK cells destroy autologous BECs in the presence of interferon alpha (IFN-α) synthesized by TLR 3 ligand (TLR3-L)-stimulated monocytes (Mo). Indeed, IFN-α production by hepatic Mo is significantly increased in patients with PBC compared to disease controls. There were also marked increases in the cytotoxic activity of hepatic NK cells from PBC patients compared to NK cells from controls but only when the NK cells were prepared following ligation of both TLR3-L- and TLR4-L-stimulated LMC. These functional data are supported by the immunohistochemical observation of an increased presence of CD56-positive NK cells scattered around destroyed small bile ducts more frequently in liver tissues from PBC patients than controls.
CONCLUSION: These data highlight critical differences in the varied roles of Mo and NK cells following TLR3-L and TLR4-L stimulation. 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21400555      PMCID: PMC3077894          DOI: 10.1002/hep.24194

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

Review 1.  Molecular mimicry and primary biliary cirrhosis: premises not promises.

Authors:  J Van de Water; H Ishibashi; R L Coppel; M E Gershwin
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

2.  Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space-time clustering analysis.

Authors:  Richard J Q McNally; Samantha Ducker; Oliver F W James
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

Review 3.  Primary biliary cirrhosis: an orchestrated immune response against epithelial cells.

Authors:  M E Gershwin; A A Ansari; I R Mackay; Y Nakanuma; A Nishio; M J Rowley; R L Coppel
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

4.  The activating receptor NKp46 is essential for the development of type 1 diabetes.

Authors:  Chamutal Gur; Angel Porgador; Moran Elboim; Roi Gazit; Saar Mizrahi; Noam Stern-Ginossar; Hagit Achdout; Hormas Ghadially; Yuval Dor; Tomer Nir; Victoria Doviner; Oren Hershkovitz; Michal Mendelson; Yaakov Naparstek; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2009-12-20       Impact factor: 25.606

5.  Autoimmunity: increasing suspects in the CD4+ T cell lineup.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

6.  Apotopes and the biliary specificity of primary biliary cirrhosis.

Authors:  Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; Ross L Coppel; Ian R Mackay; Gregory J Gores; Aftab A Ansari; Judy Van de Water; M Eric Gershwin
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

7.  Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients.

Authors:  Georg Stary; Irene Klein; Sabine Kohlhofer; Frieder Koszik; Thomas Scherzer; Leonhard Müllauer; Heribert Quendler; Norbert Kohrgruber; Georg Stingl
Journal:  Blood       Date:  2009-08-18       Impact factor: 22.113

Review 8.  IDO expression by dendritic cells: tolerance and tryptophan catabolism.

Authors:  Andrew L Mellor; David H Munn
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

9.  Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.

Authors:  Barbara Oliviero; Stefania Varchetta; Enrica Paudice; Giuseppe Michelone; Marco Zaramella; Domenico Mavilio; Francesca De Filippi; Savino Bruno; Mario U Mondelli
Journal:  Gastroenterology       Date:  2009-05-24       Impact factor: 22.682

10.  Natural killer group 2 member D, its ligands, and liver disease: good or bad?

Authors:  Bin Gao
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

View more
  55 in total

Review 1.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

2.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

Review 3.  Therapeutic targets for cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Opin Ther Targets       Date:  2015-10-19       Impact factor: 6.902

Review 4.  Pathogen infections and primary biliary cholangitis.

Authors:  A Tanaka; P S C Leung; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2018-09-17       Impact factor: 4.330

5.  Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

Authors:  Yongyin Li; Weibin Wang; Libo Tang; Xuanqiu He; Xin Yan; Xiaoyong Zhang; Youfu Zhu; Jian Sun; Yongquan Shi; Xiong Ma; Ian R Mackay; M Eric Gershwin; Ying Han; Jinlin Hou
Journal:  Hepatology       Date:  2015-03-18       Impact factor: 17.425

Review 6.  Natural killer cells in liver diseases.

Authors:  Meijuan Zheng; Haoyu Sun; Zhigang Tian
Journal:  Front Med       Date:  2018-04-19       Impact factor: 4.592

Review 7.  Role of autoimmunity in primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

Review 8.  Cell mediators of autoimmune hepatitis and their therapeutic implications.

Authors:  Aldo J Montano-Loza; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2014-12-09       Impact factor: 3.199

Review 9.  Organ-specific phenotypic and functional features of NK cells in humans.

Authors:  Richa Sharma; Asmita Das
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

10.  Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA.

Authors:  Patrick S C Leung; Jinjun Wang; Phornnop Naiyanetr; Thomas P Kenny; Kit S Lam; Mark J Kurth; M Eric Gershwin
Journal:  J Autoimmun       Date:  2013-01-24       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.